Elypta Company
Preventing cancer mortality by developing a metabolism-based liquid biopsy platform for early detection and monitoring
%20.jpg)
Founded Date:
2017
Investor Type:
For Profit
Employee Number:
11-50
Funding Status:
Seed
Technology:
Small Molecules
Industry:
PharmTech
Headquarters:
Stockholm, Stockholms Lan, Sweden
Estimated Revenue:
Less than $1M